Sanofi, GlaxoSmithKline to begin human trials of COVID-19 vaccine; read details
London: Sanofi and GlaxoSmithKline say they are beginning human trials of a potential vaccine for COVID-19 after positive results from ...
Read moreDetails
London: Sanofi and GlaxoSmithKline say they are beginning human trials of a potential vaccine for COVID-19 after positive results from ...
Read moreDetailsLondon: Pharmaceutical giant GlaxoSmithKline Thursday said it plans to produce 1 billion doses of coronavirus vaccine adjuvant, an ingredient that ...
Read moreDetails
The news that a clutch of Bihar’s senior babus may soon head to Delhi on Central deputation, in the wake...
Read moreDetails
The big question being asked 24 hours after US President Donald Trump announced a five-day pause on the ongoing...
Read moreDetails
In a major development on 23 March, US President Donald Trump said in a Truth Social post 23 days after...
Read moreDetails
The world is reeling under an unprecedented fuel and gas crisis. The prevailing situation is creating panic in domestic kitchens,...
Read moreDetails